Elcelyx Therapeutics, Inc.
Records under this name other than patents Elcelyx Therapeutics, Inc. holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned.
Back to Elcelyx Therapeutics, Inc.
Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 8,796,338 | Biguanide compositions and methods of treating metabolic disorders Formerly held In force · USPTO record | In force | USPTO record | |
| US 9,050,292 | Chemosensory Receptor Ligand-Based Therapies Formerly held In force · Medium confidence | In force | Medium confidence | |
| US 9,463,170 | Chemosensory Receptor Ligand-Based Therapies Formerly held In force · Medium confidence | In force | Medium confidence | |
| US 9,480,663 | Biguanide compositions and methods of treating metabolic disorders Formerly held In force · USPTO record | In force | USPTO record | |
| US 9,481,642 | Biguanide compositions and methods of treating metabolic disorders Formerly held In force · USPTO record | In force | USPTO record | |
| US 9,572,784 | Compositions comprising statins, biguanides and further agents for reducing cardiometabolic risk Formerly held In force · USPTO record | In force | USPTO record | |
| US 9,770,422 | Compositions and methods for treating metabolic disorders Formerly held In force · USPTO record | In force | USPTO record | |
| US 9,962,344 | Chemosensory Receptor Ligand-Based Therapies Formerly held In force · Medium confidence | In force | Medium confidence | |
| US 10,028,923 | Biguanide compositions and methods of treating metabolic disorders Formerly held In force · USPTO record | In force | USPTO record | |
| US 10,154,972 | Biguanide Compositions and Methods of Treating Metabolic Disorders Formerly held In force · Medium confidence | In force | Medium confidence |